¿Es rapeseed sophorolipids seguro durante el embarazo?
No harmonised ECHA/Annex VI reproductive classification or SCCS/CIR safety assessment for ‘sophorolipids’ was found; ECHA registration dossiers list sophorolipids as fermentation products (various mixtures) and do not apply reproductive hazard classifications, and peer-reviewed reviews characterize sophorolipids as biosurfactant glycolipids with low general toxicity but without specific teratogenic/reproductive evidence. Therefore default (no evidence) scoring is applied. ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.235.632?utm_source=openai))
Related ingredients
Frequently asked questions
- ¿Es rapeseed sophorolipids seguro durante el embarazo?
- No harmonised ECHA/Annex VI reproductive classification or SCCS/CIR safety assessment for ‘sophorolipids’ was found; ECHA registration dossiers list sophorolipids as fermentation products (various mixtures) and do not apply reproductive hazard classifications, and peer-reviewed reviews characterize sophorolipids as biosurfactant glycolipids with low general toxicity but without specific teratogenic/reproductive evidence. Therefore default (no evidence) scoring is applied. ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.235.632?utm_source=openai))
- ¿Es rapeseed sophorolipids seguro durante la lactancia?
- No data were located showing placental or milk transfer or reproductive/endocrine effects from topical/application exposures to sophorolipids; ECHA dossiers and recent reviews describe composition, production and general toxicology but do not report breastfeeding-specific hazards, so default no-evidence scoring is used. ([echa.europa.eu](https://echa.europa.eu/registration-dossier/-/registered-dossier/12734/4/8?utm_source=openai))
- ¿Es rapeseed sophorolipids seguro para la piel del bebé?
- No evidence of reproductive or developmental hazard was identified; topical absorption for adult cosmetic use is generally considered low for high-molecular-weight glycolipids in formulation matrices (no evidence of high systemic bioavailability). Because infants 0–3 years have an immature barrier, exposure score for baby skin is increased by +1 (per your instructions) from negligible to low/measurable, though no infant-specific absorption studies were found. ([researchmgt.monash.edu](https://researchmgt.monash.edu/ws/portalfiles/portal/420844377/412667010_oa.pdf?utm_source=openai))
- ¿Cómo puntúa VeriMom a rapeseed sophorolipids?
- VeriMom puntúa rapeseed sophorolipids en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a rapeseed sophorolipids en el embarazo?
- Consulta nuestra lista de alternativas seguras a rapeseed sophorolipids según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.